Controlled Substances & Dangerous Drugs
DEA Announcement Regarding Registration Renewals
DEA has announced that starting January 1, 2017, only one renewal notification will be sent to the registrant. Additionally, renewal applications must be received no later than the current license expiration date. If you allow your license to expire, a new application must be submitted. Late renewal applications will not be accepted by the DEA.
This notice affects both Researchers (renewal form 225a) and Practitioners (renewal form 224a). The notice, “Change in DEA Registration Application Renewal Notification Reminder”, can be viewed at: https://www.deadiversion.usdoj.gov/drugreg/index.html.
Different legal and policy requirements apply to investigators who are performing bench research or animal research using Controlled Substances and to health care and veterinary practitioners using controlled substances to provide care to patients/clients. Emory University's Policy for Research Use of Controlled Substances ("Controlled Substances Policy") governs investigators who are performing bench research or animal research using Controlled Substances, while practitioner licensing requirements, health care facility policies govern medical/veterinary practice use of Controlled Substances and IRB policies govern human subject research use of Controlled Substances.
Investigators whose research falls within the scope of the Controlled Substances Policy are expected to be knowledgeable of and adhere to the requirements of applicable federal and state laws/regulations and the Emory Controlled Substances Policy. Failure to follow applicable laws/regulations or the Controlled Substances Policy can result in loss of privilege to use Controlled Substances in research at Emory; civil action or license revocation by licensing agencies; and/or criminal prosecution by law enforcement agencies.
The applicable laws/regulations and Controlled Substances Policy set forth requirements within the following broad categories: (a) registering with state and federal agencies; (b) establishing certain physical security measures; (c) establishing personnel screening measures; (d) procuring Controlled Substances; (e) disposing of Controlled Substances; and (f) record keeping.
Similarly, there are requirements associated with the use of Dangerous Drugs. The Georgia Code calls prescription drugs that are not Controlled Substances by the name Dangerous Drugs. Dangerous Drugs are those that are available only by prescription from a licensed health care professional or those authorized by the state of Georgia. As with with Controlled Substances there are permit requirements through the Georgia Board of Pharmacy.
The following FAQ document provides a more in-depth review of State and Federal Requirements regarding obtaining Dangerous Drugs and/or Controlled Substances for use in animal or bench research: